Anaplasma phagocytophilum: Deceptively simple or simply deceptive?

Future Microbiology

Volumn 7, Issue 6, 2012, Pages 719-731

  Severo, Maiara S ^a   Stephens, Kimberly D ^a   Kotsyfakis, Michail ^b   Pedra, Joao Hf ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF PARASITOLOGY   (Czech Republic)

Author keywords

obligate intracellular bacterium; rickettsial agents; ticks; vector borne diseases

Indexed keywords

ABELSON KINASE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYL BETA CYCLODEXTRIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PERILIPIN; PORIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMATACEAE INFECTION; APOPTOSIS; AUTOPHAGY; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GENE EXPRESSION; GENE LOCUS; IMMUNE SYSTEM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; REVIEW; TICK INFESTATION; TROPISM;

ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; ASIA; BIOMEDICAL RESEARCH; EHRLICHIOSIS; EUROPE; HUMANS; IMMUNE EVASION; TICK-BORNE DISEASES; TICKS; UNITED STATES;

EID: 84862569152     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.45     Document Type: Review

References (81)

1. Rikihisa Y. Anaplasma phagocytophilum and Ehrlichia chaffeensis: subversive manipulators of host cells. Nat. Rev. Microbiol. 8(5), 328-339 (2010).
2. Popov VL, Han VC, Chen SM et al. Ultrastructural differentiation of the genogroups in the genus Ehrlichia. J. Med. Microbiol. 47(3), 235-251 (1998). (Pubitemid 28090053)
3. Troese MJ, Kahlon A, Ragland SA et al. Proteomic analysis of Anaplasma phagocytophilum during infection of human myeloid cells identifies a protein that is pronouncedly upregulated on the infectious dense-cored cell. Infect. Immun. 79(11), 4696-4707 (2011).
4. Dumler JS. The biological basis of severe outcomes in Anaplasma phagocytophilum infection. FEMS Immunol. Med. Microbiol. 64(1), 13-20 (2012).
5. Morissette E, Massung RF, Foley JE, Alleman AR, Foley P, Barbet AF. Diversity of Anaplasma phagocytophilum strains, USA. Emerg. Infect. Dis. 15(6), 928-931 (2009).
6. Foley J, Nieto NC, Madigan J, Sykes J. Possible differential host tropism in Anaplasma phagocytophilum strains in the western United States. Ann. NY Acad. Sci. 1149, 94-97 (2008).
7. Hoar BR, Nieto NC, Rhodes DM, Foley JE. Evaluation of sequential coinfection with Anaplasma phagocytophilum and Anaplasma marginale in cattle. Am. J. Vet. Res. 69(9), 1171-1178 (2008).
8. Bown KJ, Lambin X, Ogden NH et al. Delineating Anaplasma phagocytophilum ecotypes in coexisting, discrete enzootic cycles. Emerg. Infect. Dis. 15(12), 1948-1954 (2009).
9. Massung RF, Priestley RA, Miller NJ, Mather TN, Levin ML. Inability of a variant strain of Anaplasma phagocytophilum to infect mice. J. Infect. Dis. 188(11), 1757-1763 (2003). (Pubitemid 38016229)
10. Rejmanek D, Bradburd G, Foley J. Molecular characterization reveals distinct genospecies of Anaplasma phagocytophilum from diverse North American hosts. J. Med. Microbiol. 61(Pt 2), 204-212 (2012).
11. Rejmanek D, Foley P, Barbet A, Foley J. Evolution of antigen variation in the tick-borne pathogen Anaplasma phagocytophilum. Mol. Biol. Evol. 29(1), 391-400 (2011).
12. Barbet AF, Lundgren AM, Alleman AR et al. Structure of the expression site reveals global diversity in MSP2 (P44) variants in Anaplasma phagocytophilum. Infect. Immun. 74(11), 6429-6437 (2006). (Pubitemid 44657425)
13. Wang X, Cheng Z, Zhang C, Kikuchi T, Rikihisa Y. Anaplasma phagocytophilum p44 mRNA expression is differentially regulated in mammalian and tick host cells: involvement of the DNA binding protein ApxR. J. Bacteriol. 189(23), 8651-8659 (2007). (Pubitemid 350210035)
14. Dunning Hotopp JC, Lin M, Madupu R et al. Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet. 2(2), e21 (2006).
15. Xiong Q, Wang X, Rikihisa Y. High-cholesterol diet facilitates Anaplasma phagocytophilum infection and up-regulates macrophage inflammatory protein-2 and CXCR2 expression in apolipoprotein E-deficient mice. J. Infect. Dis. 195(10), 1497-1503 (2007). (Pubitemid 46717468)
16. Manzano-Roman R, Almazan C, Naranjo V, Blouin EF, Kocan KM, De La Fuente J. Expression of perilipin in human promyelocytic cells in response to Anaplasma phagocytophilum infection results in modified lipid metabolism. J. Med. Microbiol. 57(Pt 2), 159-163 (2008). (Pubitemid 351231398)
17. Xiong Q, Lin M, Rikihisa Y. Cholesterol-dependent Anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway. PLoS Pathog. 5, e1000329 (2009).
18. Xiong Q, Rikihisa Y. Subversion of NPC1 pathway of cholesterol transport by Anaplasma phagocytophilum. Cell. Microbiol. 14, 560-576 (2012).
19. Nelson CM, Herron MJ, Felsheim RF et al. Whole genome transcription profiling of Anaplasma phagocytophilum in human and tick host cells by tiling array analysis. BMC Genomics 9, 364 (2008).
20. Garcia-Garcia JC, Rennoll-Bankert KE, Pelly S, Milstone AM, Dumler JS. Silencing of host cell CYBB gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect. Immun. 77(6), 2385-2391 (2009).
21. Park J, Kim KJ, Choi KS, Grab DJ, Dumler JS. Anaplasma phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins. Cell. Microbiol. 6(8), 743-751 (2004). (Pubitemid 39089041)
22. Ijdo JW, Carlson AC, Kennedy EL. Anaplasma phagocytophilum AnkA is tyrosine-phosphorylated at EPIYA motifs and recruits SHP-1 during early infection. Cell. Microbiol. 9(5), 1284-1296 (2007). (Pubitemid 46552880)
23. Lin M, Den Dulk-Ras A, Hooykaas PJ, Rikihisa Y. Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection. Cell. Microbiol. 9(11), 2644-2657 (2007). (Pubitemid 47500516)
24. Niu H, Kozjak-Pavlovic V, Rudel T, Rikihisa Y. Anaplasma phagocytophilum Ats-1 is imported into host cell mitochondria and interferes with apoptosis induction. PLoS Pathog. 6(2), e1000774 (2010).
25. Munderloh UG, Lynch MJ, Herron MJ et al. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum. Vet. Microbiol. 101(1), 53-64 (2004). (Pubitemid 38765147)
26. Herron MJ, Ericson ME, Kurtti TJ, Munderloh UG. The interactions of Anaplasma phagocytophilum, endothelial cells, and human neutrophils. Ann. NY Acad. Sci. 1063, 374-382 (2005).
27. Choi KS, Garyu J, Park J, Dumler JS. Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect. Immun. 71(8), 4586-4594 (2003). (Pubitemid 36919925)
28. Akkoyunlu M, Malawista SE, Anguita J, Fikrig E. Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect. Immun. 69(9), 5577-5588 (2001). (Pubitemid 32786494)
29. Schaff UY, Trott KA, Chase S et al. Neutrophils exposed to A. phagocytophilum under shear stress fail to fully activate, polarize, and transmigrate across inflamed endothelium. Am. J. Physiol. Cell Physiol. 299(1), C87-C96 (2010).
30. Thomas V, Fikrig E. Anaplasma phagocytophilum specifically induces tyrosine phosphorylation of ROCK1 during infection. Cell. Microbiol. 9(7), 1730-1737 (2007). (Pubitemid 46958799)
31. Lin M, Rikihisa Y. Obligatory intracellular parasitism by Ehrlichia chaffeensis and Anaplasma phagocytophilum involves caveolae and glycosylphosphatidylinositol-anchored proteins. Cell. Microbiol. 5(11), 809-820 (2003). (Pubitemid 37309278)
32. Herron MJ, Nelson CM, Larson J, Snapp KR, Kansas GS, Goodman JL. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science 288(5471), 1653-1656 (2000). (Pubitemid 30387433)
33. Goodman JL, Nelson CM, Klein MB, Hayes SF, Weston BW. Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. J. Clin. Invest. 103(3), 407-412 (1999). (Pubitemid 29069991)
34. Granick JL, Reneer DV, Carlyon JA, Borjesson DL. Anaplasma phagocytophilum infects cells of the megakaryocytic lineage through sialylated ligands but fails to alter platelet production. J. Med. Microbiol. 57(Pt 4), 416-423 (2008). (Pubitemid 351537013)
35. Carlyon JA, Akkoyunlu M, Xia L et al. Murine neutrophils require a1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum. Blood 102(9), 3387-3395 (2003). (Pubitemid 37321339)
36. Yago T, Leppanen A, Carlyon JA et al. Structurally distinct requirements for binding of P-selectin glycoprotein ligand-1 and sialyl Lewis X to Anaplasma phagocytophilum and P-selectin. J. Biol. Chem. 278(39), 37987-37997 (2003). (Pubitemid 37175329)
37. Sarkar M, Reneer DV, Carlyon JA. Sialyl-Lewis X-independent infection of human myeloid cells by Anaplasma phagocytophilum strains HZ and HGE1. Infect. Immun. 75(12), 5720-5725 (2007). (Pubitemid 350207809)
38. Reneer DV, Kearns SA, Yago T et al. Characterization of a sialic acid-and P-selectin glycoprotein ligand-1-independent adhesin activity in the granulocytotropic bacterium Anaplasma phagocytophilum. Cell. Microbiol. 8(12), 1972-1984 (2006). (Pubitemid 44687334)
39. Reneer DV, Troese MJ, Huang B, Kearns SA, Carlyon JA. Anaplasma phagocytophilum PSGL-1-independent infection does not require Syk and leads to less efficient AnkA delivery. Cell. Microbiol. 10(9), 1827-1838 (2008).
40. Mastronunzio JE, Kurscheid S, Fikrig E. Post-genomic analyses reveal development of infectious Anaplasma phagocytophilum during transmission from ticks to mice. J. Bacteriol. 194(9), 2238-2247 (2012).
41. Niu H, Rikihisa Y, Yamaguchi M, Ohashi N. Differential expression of VirB9 and VirB6 during the life cycle of Anaplasma phagocytophilum in human leucocytes is associated with differential binding and avoidance of lysosome pathway. Cell. Microbiol. 8(3), 523-534 (2006). (Pubitemid 43356040)
42. Niu H, Yamaguchi M, Rikihisa Y. Subversion of cellular autophagy by Anaplasma phagocytophilum. Cell. Microbiol. 10(3), 593-605 (2008). (Pubitemid 351194089)
43. Huang B, Hubber A, Mcdonough JA, Roy CR, Scidmore MA, Carlyon JA. The Anaplasma phagocytophilum-occupied vacuole selectively recruits Rab-GTPases that are predominantly associated with recycling endosomes. Cell. Microbiol. 12(9), 1292-1307 (2010).
44. Huang B, Troese MJ, Ye S et al. Anaplasma phagocytophilum APH-1387 is expressed throughout bacterial intracellular development and localizes to the pathogen-occupied vacuolar membrane. Infect. Immun. 78(5), 1864-1873 (2010).
45. Huang B, Troese MJ, Howe D et al. Anaplasma phagocytophilum APH-0032 is expressed late during infection and localizes to the pathogen-occupied vacuolar membrane. Microb. Pathogen.49(5), 273-284 (2010).
46. Huang B, Ojogun N, Ragland SA, Carlyon JA. Monoubiquitinated proteins decorate the Anaplasma phagocytophilum-occupied vacuolar membrane. FEMS Immunol. Med. Microbiol. 64(1), 32-41 (2012).
47. Choi KS, Scorpio DG, Dumler JS. Anaplasma phagocytophilum ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kB nuclear translocation. J. Infect. Dis. 189(10), 1921-1925 (2004). (Pubitemid 38657229)
48. Kim HY, Rikihisa Y. Roles of p38 mitogen-activated protein kinase, NF-kB, and protein kinase C in proinflammatory cytokine mRNA expression by human peripheral blood leukocytes, monocytes, and neutrophils in response to Anaplasma phagocytophila. Infect. Immun. 70(8), 4132-4141 (2002). (Pubitemid 34792649)
49. Johns JL, Macnamara KC, Walker NJ, Winslow GM, Borjesson DL. Infection with Anaplasma phagocytophilum induces multilineage alterations in hematopoietic progenitor cells and peripheral blood cells. Infect. Immun. 77(9), 4070-4080 (2009).
50. Johns JL, Borjesson DL. Downregulation of CXCL12 signaling and altered hematopoietic stem and progenitor cell trafficking in a murine model of acute Anaplasma phagocytophilum infection. Innate Immun. doi:10.1177/1753425911413794 (2011) (Epub ahead of print).
51. Klein MB, Hu S, Chao CC, Goodman JL. The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines. J. Infect. Dis. 182(1), 200-205 (2000). (Pubitemid 30497805)
52. Pedra JH, Tao J, Sutterwala FS et al. IL-12/23p40-dependent clearance of Anaplasma phagocytophilum in the murine model of human anaplasmosis. FEMS Immunol. Med. Microbiol. 50(3), 401-410 (2007). (Pubitemid 47041466)
53. Pedra JH, Sutterwala FS, Sukumaran B et al. ASC/PYCARD and caspase-1 regulate the IL-18/IFN-g axis during Anaplasma phagocytophilum infection. J. Immunol. 179(7), 4783-4791 (2007).
54. Sun W, Jw IJ, Telford SR III et al. Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J. Clin. Invest. 100(12), 3014-3018 (1997). (Pubitemid 28022838)
55. Pedra JH, Sukumaran B, Carlyon JA, Berliner N, Fikrig E. Modulation of NB4 promyelocytic leukemic cell machinery by Anaplasma phagocytophilum. Genomics 86(3), 365-377 (2005). (Pubitemid 41102191)
56. Pedra JH, Mattner J, Tao J et al. c-Jun NH2-terminal kinase 2 inhibits gamma interferon production during Anaplasma phagocytophilum infection. Infect. Immun. 76(1), 308-316 (2008).
57. Akkoyunlu M, Fikrig E. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect. Immun. 68(4), 1827-1833 (2000). (Pubitemid 30164805)
58. Choi KS, Webb T, Oelke M, Scorpio DG, Dumler JS. Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection. Infect. Immun. 75(6), 3124-3130 (2007). (Pubitemid 46870198)
59. Choi KS, Dumler JS. Mitogenic component in polar lipid-enriched Anaplasma phagocytophilum membranes. Clin. Vaccine Immunol. 14(10), 1260-1265 (2007). (Pubitemid 350012966)
60. Von Loewenich FD, Scorpio DG, Reischl U, Dumler JS, Bogdan C. Control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88. Eur. J. Immunol. 34(7), 1789-1797 (2004). (Pubitemid 39268778)
61. Scorpio DG, Von Loewenich FD, Gobel H, Bogdan C, Dumler JS. Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury. Clin. Vaccine Immunol. 13(7), 806-809 (2006).
62. Borjesson DL, Simon SI, Hodzic E, Ballantyne CM, Barthold SW. Kinetics of CD11b/CD18 up-regulation during infection with the agent of human granulocytic ehrlichiosis in mice. Lab. Invest. 82(3), 303-311 (2002). (Pubitemid 34242524)
63. Banerjee R, Anguita J, Roos D, Fikrig E. Infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J. Immunol. 164(8), 3946-3949 (2000). (Pubitemid 30215045)
64. Wang T, Malawista SE, Pal U et al. Superoxide anion production during Anaplasma phagocytophila infection. J. Infect. Dis. 186(2), 274-280 (2002). (Pubitemid 34773436)
65. Mott J, Rikihisa Y. Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils. Infect. Immun. 68(12), 6697-6703 (2000). (Pubitemid 32463373)
66. Thomas V, Samanta S, Fikrig E. Anaplasma phagocytophilum increases cathepsin L activity, thereby globally influencing neutrophil function. Infect. Immun. 76(11), 4905-4912 (2008).
67. Ojogun N, Barnstein B, Huang B et al. Anaplasma phagocytophilum infects mast cells via a1,3-fucosylated but not sialylated glycans and inhibits IgE-mediated cytokine production and histamine release. Infect. Immun. 79(7), 2717-2726 (2011).
68. Garcia-Garcia JC, Barat NC, Trembley SJ, Dumler JS. Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum. PLoS Pathog. 5(6), e1000488 (2009).
69. Lai TH, Kumagai Y, Hyodo M, Hayakawa Y, Rikihisa Y. The Anaplasma phagocytophilum PleC histidine kinase and PleD diguanylate cyclase two-component system and role of cyclic di-GMP in host cell infection. J. Bacteriol. 191(3), 693-700 (2009).
70. Choi KS, Park JT, Dumler JS. Anaplasma phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-activated protein kinase signal pathway. Infect. Immun. 73(12), 8209-8218 (2005). (Pubitemid 41740310)
71. Sarkar A, Hellberg L, Bhattacharyya A et al. Infection with Anaplasma phagocytophilum activates the PI3K/AKT and NF-kB survival pathways in neutrophil granulocytes. Infect. Immun. 80(4), 1615-1623 (2012).
72. Sukumaran B, Mastronunzio JE, Narasimhan S et al. Anaplasma phagocytophilum AptA modulates Erk1/2 signalling. Cell. Microbiol. 13(1), 47-61 (2011).
73. Xiong Q, Rikihisa Y. The prenylation inhibitor manumycin A reduces the viability of Anaplasma phagocytophilum. J. Med. Microbiol. 60(Pt 6), 744-749 (2011).
74. Munderloh UG, Jauron SD, Fingerle V et al. Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J. Clin. Microbiol. 37(8), 2518-2524 (1999). (Pubitemid 29337271)
75. Liu L, Narasimhan S, Dai J, Zhang L, Cheng G, Fikrig E. Ixodes scapularis salivary gland protein P11 facilitates migration of Anaplasma phagocytophilum from the tick gut to salivary glands. EMBO Rep. 12, 1196-1203 (2011).
76. Sukumaran B, Narasimhan S, Anderson J et al. An Ixodes scapularis protein required for survival of Anaplasma phagocytophilum in tick salivary glands. J. Exp. Med. 203, 1507-1517 (2006). (Pubitemid 43880327)
77. Sultana H, Neelakanta G, Kantor F et al. Anaplasma phagocytophilum induces actin phosphorylation to selectively regulate gene transcription in Ixodes scapularis ticks. J. Exp. Med. 207, 1727-1743 (2010).
78. Neelakanta G, Sultana H, Fish D, Anderson J, Fikrig E. Anaplasma phagocytophilum induces Ixodes scapularis ticks to express an antifreeze glycoprotein gene that enhances their survival in the cold. J. Clin. Invest. 120, 3179-3190 (2010).
79. Pedra J, Narasimhan S, Rendi? D et al. Fucosylation enhances colonization of ticks by Anaplasma phagocytophilum. Cell. Microbiol. 12, 1222-1234 (2010).
80. De La Fuente J, Blouin EF, Manzano-Roman R et al. Differential expression of the tick protective antigen subolesin in Anaplasma marginale-and A. phagocytophilum-infected host cells. Ann. NY Acad. Sci. 1149, 27-35 (2008).
81. Benson DA, Karsch-Mizrachi I, Clark K, Lipman DJ, Ostell J, Sawyers EW. GenBank. Nucleic Acids Res. 40(Database issue), D48-D53 (2012).